Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait

被引:34
|
作者
Liu, C. [1 ]
Yang, W. [1 ]
Pei, D. [2 ]
Cheng, C. [2 ]
Smith, C. [1 ]
Landier, W. [3 ]
Hageman, L. [3 ]
Chen, Y. [3 ]
Yang, J. J. [1 ]
Crews, K. R. [1 ]
Kornegay, N. [1 ]
Karol, S. E. [4 ]
Wong, F. L. [5 ]
Jeha, S. [4 ]
Sandlund, J. T. [4 ]
Ribeiro, R. C. [4 ]
Rubnitz, J. E. [4 ]
Metzger, M. L. [4 ]
Pui, C-H [4 ]
Evans, W. E. [1 ]
Bhatia, S. [3 ]
Relling, M. V. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[4] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
[5] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA USA
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; INFLAMMATORY-BOWEL-DISEASE; CHILDRENS-ONCOLOGY-GROUP; DRUG-METABOLISM GENES; S-METHYLTRANSFERASE; MERCAPTOPURINE INTOLERANCE; CAUCASIAN POPULATION; BLACK SUBJECTS; CHILDHOOD; POLYMORPHISM;
D O I
10.1002/cpt.463
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We performed a genomewide association study (GWAS) of primary erythrocyte thiopurine S-methyltransferase (TPMT) activity in children with leukemia (n= 1,026). Adjusting for age and ancestry, TPMT was the only gene that reached genomewide significance (top hit rs1142345 or 719A> G; P= 8.6x 10(-61)). Additional genetic variants (in addition to the three single-nucleotide polymorphisms [SNPs], rs1800462, rs1800460, and rs1142345, defining TPMT clinical genotype) did not significantly improve classification accuracy for TPMT phenotype. Clinical mercaptopurine tolerability in 839 patients was related to TPMT clinical genotype (P= 2.4x 10(-11)). Using 177 lymphoblastoid cell lines (LCLs), there were 251 SNPs ranked higher than the top TPMT SNP (rs1142345; P= 6.8x 10(-5)), revealing a limitation of LCLs for pharmacogenomic discovery. In a GWAS, TPMT activity in patients behaves as a monogenic trait, further bolstering the utility of TPMT genetic testing in the clinic.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 50 条
  • [31] Are hepatic toxic effects of thiopurine derivatives drugs related to thiopurine methyltransferase activity deficiency?
    Pageaux, GP
    Masbou, J
    Brunschwig, C
    HillaireBuys, D
    Alric, R
    Michel, H
    Larrey, D
    GASTROENTEROLOGY, 1997, 112 (04) : A1354 - A1354
  • [32] THIOPURINE PHARMACOGENETICS - CORRELATION OF THIOPURINE METHYLTRANSFERASE ACTIVITY AND 6-THIOGUANINE NUCLEOTIDE LEVELS
    LENNARD, L
    VANLOON, J
    LILLEYMAN, JS
    WEINSHILBOUM, R
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 45 - 45
  • [33] Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity
    Arenas, M
    Simpson, G
    Lewis, CM
    Shobowale-Bakre, EM
    Escuredo, E
    Fairbanks, LD
    Duley, JA
    Ansari, A
    Sanderson, JD
    Marinaki, AM
    CLINICAL CHEMISTRY, 2005, 51 (12) : 2371 - 2374
  • [34] Thiopurine S-methyltransferase activity (TPMT) is modulated by disease
    Iven, H
    Kotalczyk, A
    Gutsche, S
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R136 - R136
  • [35] PHARMACOGENETICS OF HUMAN ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY IN A FRENCH POPULATION
    TINEL, M
    BERSON, A
    PESSAYRE, D
    LETTERON, P
    CATTONI, MP
    HORSMANS, Y
    LARREY, D
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (06) : 729 - 734
  • [36] PHARMACOGENETICS OF HUMAN ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY IN A KOREAN POPULATION
    JANG, IJ
    LEE, KH
    SHIN, SG
    PARK, CW
    SOHN, DR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 171 - 171
  • [37] Monitoring thiopurine methyltransferase activity to adjust dosages of azathioprine or mercaptopurine
    Gisbert, Javier P.
    SALUD I CIENCIA, 2011, 18 (02): : 123 - 126
  • [38] IDENTIFICATION OF FACTORS REGULATING THIOPURINE METHYLTRANSFERASE ACTIVITY IN A NORWEGIAN POPULATION
    KLEMETSDAL, B
    STRAUME, B
    WIST, E
    AARBAKKE, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (02) : 147 - 152
  • [39] THIOPURINE METHYLTRANSFERASE IN UREMIA - ELEVATED ERYTHROCYTE ACTIVITY AND PLASMA INHIBITORS
    PAZMINO, PA
    SLADEK, SL
    WEINSHILBOUM, RM
    CLINICAL RESEARCH, 1979, 27 (04): : A668 - A668
  • [40] THIOPURINE METHYLTRANSFERASE BIOCHEMICAL GENETICS - HUMAN-LYMPHOCYTE ACTIVITY
    VANLOON, JA
    WEINSHILBOUM, RM
    BIOCHEMICAL GENETICS, 1982, 20 (7-8) : 637 - 658